ℹ️ How are these calculated?
🎯 Investment Thesis
Near ATH ($227 vs $231) after Q4 beat drove a post-earnings rally. Analysts sharply divided: UBS Buy $260 and Rosenblatt Buy $240 vs Goldman Sachs Sell $175. JP Morgan Overweight $227 (exactly at current price). The reshoring thesis is intact — 4 new US fabs position TI as the analog reshoring champion. Dividend aristocrat with 20+ years of increases.
⚠️ Key Risk
Goldman Sachs maintains Sell at $175 — sees 23% downside from current levels. At 29x PE for a company with -2% revenue growth, valuation assumes a recovery that hasn't fully materialized. New fab capex ($5B/yr) pressuring FCF. Only 2% below ATH — minimal margin of safety. Jefferies Hold $210 is another cautious voice.
By The Numbers
Event Impact
Analog/embedded chips used in DC power management and industrial systems. Indirect AI beneficiary.
Defense/industrial exposure provides mild benefit.
Analog chips used in quantum control electronics.
Reshoring champion — building 4 new US fabs. Benefits from China trade restrictions on competitors.
$12B debt with $5B/yr fab capex. At 29x PE with -2% revenue growth, rate-sensitive. New fab buildout needs cheap capital.
Analog chips for power management in grid infrastructure, industrial controls, smart meters, and inverters. Every grid sensor and power converter needs TI chips.
CHIPS Act subsidies for 4 new US fabs. Defense analog chip supply chain. Strategic semiconductor reshoring priority.
Price Targets
Upcoming Catalysts
Competitive Landscape
Company Background
Founded 1951. Invented the integrated circuit (Jack Kilby, Nobel Prize). Transformed into the world's largest analog chipmaker. Steady compounder for decades.